Literature DB >> 22197750

Age-related changes in visual function in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia.

Minzhong Yu1, Gwen Sturgill-Short, Preethi Ganapathy, Amany Tawfik, Neal S Peachey, Sylvia B Smith.   

Abstract

Homocysteine is an amino acid required for the metabolism of methionine. Excess homocysteine is implicated in cardiovascular and neurological disease and new data suggest a role in various retinopathies. Mice lacking cystathionine-beta-synthase (cbs(-/-)) have an excess of retinal homocysteine and develop anatomical abnormalities in multiple retinal layers, including photoreceptors and ganglion cells; heterozygous (cbs(+/-)) mice demonstrate ganglion cell loss and mitochondrial abnormalities in the optic nerve. The purpose of the present study was to determine whether elevated homocysteine, due to absent or diminished cbs, alters visual function. We examined cbs(-/-) (3 weeks) and cbs(+/-) mice (5, 10, 15, 30 weeks) and results were compared to those obtained from wild type (WT) littermates. Conventional dark- and light-adapted ERGs were recorded, along with dc-ERG to assess retinal pigment epithelial (RPE) function. The visual evoked potential (VEP) was used to assess transmission to the visual cortex. The amplitudes of the major ERG components were reduced in cbs(-/-) mice at age 3 weeks and VEPs were delayed markedly. These findings are consistent with the early retinal disruption observed anatomically in these mice. In comparison, at 3 weeks of age, responses of cbs(+/-) mice did not differ significantly from those of WT mice. Functional abnormalities were not observed in cbs(+/-) mice until 15 weeks of age, at which time amplitude reductions were noted for the ERG a- and b-wave and the light peak component, but not for other components generated by the RPE. VEP implicit times were delayed in cbs(+/-) mice at 15 and 30 weeks, while VEP amplitudes were unaffected. The later onset of functional defects in cbs(+/-) mice is consistent with a slow loss of ganglion cells reported previously in the heterozygous mutant. Light peak abnormalities indicate that RPE function is also compromised in older cbs(+/-) mice. The data suggest that severe elevations of homocysteine are associated with marked alterations of retinal function while modest homocysteine elevation is reflected in milder and delayed alterations of retinal function. The work lays the foundation to explore the role of homocysteine in retinal diseases such as glaucoma and optic neuropathy. Copyright Â
© 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197750      PMCID: PMC3368555          DOI: 10.1016/j.exer.2011.12.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  36 in total

1.  Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice.

Authors:  N S Peachey; L Roveri; A Messing; M A McCall
Journal:  Vis Neurosci       Date:  1997 Jul-Aug       Impact factor: 3.241

2.  Evaluation of plasma homocysteine and risk of age-related macular degeneration.

Authors:  Johanna M Seddon; Gary Gensler; Michael L Klein; Roy C Milton
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

3.  Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria.

Authors:  Efthymia K Tsina; Deborah L Marsden; Ronald M Hansen; Anne B Fulton
Journal:  Arch Ophthalmol       Date:  2005-08

4.  Ocular complications and a new surgical approach to lens dislocation in homocystinuria due to cystathionine-beta-synthetase deficiency.

Authors:  H Gerding
Journal:  Eur J Pediatr       Date:  1998-04       Impact factor: 3.183

5.  Disturbed visual system function in methionine synthase deficiency.

Authors:  Charlotte M Poloschek; Brian Fowler; Renate Unsold; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-18       Impact factor: 3.117

6.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Plasma homocysteine is elevated in patients with exfoliation syndrome.

Authors:  Roberto M Vessani; Robert Ritch; Jeffrey M Liebmann; Mark Jofe
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

8.  Light-evoked responses of the mouse retinal pigment epithelium.

Authors:  Jiang Wu; Neal S Peachey; Alan D Marmorstein
Journal:  J Neurophysiol       Date:  2003-11-12       Impact factor: 2.714

Review 9.  Hypercoagulable states and central retinal vein occlusion.

Authors:  J Michael Lahey; John J Kearney; Murat Tunc
Journal:  Curr Opin Pulm Med       Date:  2003-09       Impact factor: 3.155

Review 10.  Mitochondrial dysfunction as a cause of optic neuropathies.

Authors:  Valerio Carelli; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Prog Retin Eye Res       Date:  2004-01       Impact factor: 21.198

View more
  34 in total

1.  A Chemical Mutagenesis Screen Identifies Mouse Models with ERG Defects.

Authors:  Jeremy R Charette; Ivy S Samuels; Minzhong Yu; Lisa Stone; Wanda Hicks; Lan Ying Shi; Mark P Krebs; Jürgen K Naggert; Patsy M Nishina; Neal S Peachey
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

3.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

4.  Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

Authors:  Kyoung-In Cho; Dosuk Yoon; Minzhong Yu; Neal S Peachey; Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-04-03       Impact factor: 9.261

5.  Increased ER stress as a mechanism of retinal neurovasculopathy in mice with severe hyperhomocysteinemia.

Authors:  Amany Tawfik; Sylvia B Smith
Journal:  Austin J Clin Ophthalmol       Date:  2014-06-16

Review 6.  Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.

Authors:  Sunny E Ohia; Jenaye Robinson; Leah Mitchell; Kalu K Ngele; Segewkal Heruye; Catherine A Opere; Ya Fatou Njie-Mbye
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-07       Impact factor: 2.671

7.  Impact of MCT1 Haploinsufficiency on the Mouse Retina.

Authors:  Neal S Peachey; Minzhong Yu; John Y S Han; Sylvain Lengacher; Pierre J Magistretti; Luc Pellerin; Nancy J Philp
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia.

Authors:  Shanu Markand; Alan Saul; Penny Roon; Puttur Prasad; Pamela Martin; Rima Rozen; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

9.  Spontaneous optic nerve compression in the osteopetrotic (op/op) mouse: a novel model of myelination failure.

Authors:  Yoichi Kondo; Jenna M Ramaker; Abigail B Radcliff; Simona Baldassari; Joshua A Mayer; James N Ver Hoeve; Chuan-Li Zhang; Shing-Yan Chiu; Raymond J Colello; Ian D Duncan
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

10.  A novel role of complement in retinal degeneration.

Authors:  Minzhong Yu; Weilin Zou; Neal S Peachey; Thomas M McIntyre; Jinbo Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.